// App-Quantinova.ai

PB1049 : Characterisation of anti-TFPI Kunitz domain 3 antibodies that selectively inhibit protein S cofactor function.

Researchers

Presenter

  • A. Petri

Principal Investigators

  • D. Jones

  • Y. Xu

  • J. Ahnstrm

  • J. Crawley

Medical Centers

  • NCRI and Imperial College London, London, United Kingdom

  • The Francis Crick Institute, London, United Kingdom

  • St George's, University of London, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • folitixorin calcium

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved